Human Insulin Like Growth Factor-I Recombinant

Catalog #
90166-A
$130 *
Size: 20 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant Human IGF-1 is a disulfide-linked monomeric protein consisting of 71 amino acid residues. IGF-1 migrates as an approximately 8 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human IGF-1 mature chain was expressed in E. coli.

Synonyms
Insulin-Like Growth Factor 1, Somatomedin C, IGF1
Product Info
Storage and Usage
Citations
Species
Human
Host Species/Expression System
E. coli
Purity
≥95% by SDS-PAGE and HPLC
Format
lyophilized protein
Formulation
Lyophilized from 0.2 µm filtered PBS, pH 7.4.
MW
8 kDa
Endotoxin Level
<0.1 ng/µg (1 EU/µg), using the LAL gel clot method.
Biological Activity

The ED50 was determined by a cell proliferation assay using FDC-P1 cells is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 107 units/mg.

UniProt #
P01343
Background
Insulin-like growth factor I, also known as somatomedin C, is the dominant effector of growth hormone and is structurally homologous to proinsulin. Human IGF-I is synthesized as two precursor isoforms with N- and alternate C- terminal propeptides. These isoforms are differentially expressed by various tissues. The 7.6 kDa mature IGF-I is identical between isoforms and is generated by proteolytic removal of the N- and C- terminal regions. Mature human IGF-I shares 94% and 96% a.a. sequence identity with mouse and rat IGF-I, respectively, and exhibits cross-species activity. It shares 64% aa sequence identity with mature human IGF-II. Circulating IGF-I is produced by hepatocytes, while local IGF-I is produced by many other tissues in which it has paracrine effects.
References
1. J. Clin. Endocrinol. Metab. October 1, 2009. 94 (10): 3913-3921.
2. Mol. Biol. Cell, Sep 2009, 20: 3810 - 3817.
3. Endocrinology, Sep 2009, 150: 4395 - 4403.